Roundhill GLP-1 & Weight Loss ETF is an actively managed exchange-traded fund focused on companies involved in GLP-1 therapies and broader weight management solutions. The fund is designed to provide concentrated exposure to pharmaceutical and biotechnology businesses developing, commercializing, or supporting treatments for obesity and related metabolic conditions. Its portfolio can also include derivative instruments tied to companies in this theme, allowing the strategy to capture a wider range of market participants across the weight-loss drug ecosystem. Roundhill GLP-1 & Weight Loss ETF serves investors seeking targeted access to one of the most closely watched healthcare segments, linking the growth of weight management innovation with the public markets. The fund is part of Roundhill Investments’ thematic ETF lineup and is structured to reflect a specialized view of the global healthcare and pharmaceutical landscape.
United States
What share of all ETF conversation is about OZEM?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% 0 | 0% +0 | 0% 0 | 0% +0 |
Of the messages about OZEM that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | — | — | 94.87% | ||
| Bearish | — | — | — | 5.13% |
Of the messages about OZEM that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Technical Analysis | — | 100% | 100% | 100% | ||
| Macro | — | 0% | 0% | 0% |
Of the messages about OZEM, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | — | 100% | 84% | 60.49% | ||
| Newcomers | — | 0% | 16% | 39.51% |
Investors talking about OZEM also mention
| # | Name | Attention |
|---|---|---|
| 1 | Eli Lilly and CompanyLLY | 0.14%+0.05 |
| 2 | Viking Therapeutics, Inc.VKTX | 0.18%0 |
| 3 | Novo Nordisk A/S Sponsored ADRNVO | 0.14%-0.04 |
| 4 | TERN - Terns Pharmaceuticals, Inc. | —— |
| 5 | YieldMax NVDA Option Income Strategy ETFNVDY | 0.04%+0.02 |
| 6 | Structure Therapeutics Inc. American Depositary SharesGPCR | 0%new |
| 7 | YieldMax COIN Option Income Strategy ETFCONY | 0%0 |
| 8 | ProShares Bitcoin Strategy ETFBITO | 0.01%+0.01 |
| 9 | Madrigal Pharmaceuticals Inc.MDGL | 0%-0.02 |
| 10 | UnitedHealth Group IncorporatedUNH | 0%-0.02 |